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PREFACE
The task assigned to the National Research Council Committee on
Toxicology proved to be a challenging one. We were presented with the
description of an occupational health program developed by the
National Aeronautics and Space Administration (NASA) and applied to
about 50,000 employees and contractors in operating facilities around
the country over a period of several years. Healtt; services available
to NASA employees have included periodic medical examinations planned
primarily for purposes of personal health maintenance, with less
emphasis on the need to maintain medical surveillance of those workers
who had ac'..ual or potential expcsure to hazardous chemical or physical
agents. Recommended NASA examinations have been of rather elaborate
scope, including a variety of laboratory procedures now recognized, as
a result of observations by the Canadian Task Force on the Periodic
Health Examination (1979) and by others, as having little clinical
justification as routine procedures for well persons. The cost
effectiveness of such procedures has also been challenged. Yet the
physical and financial burden of carrying out a large volume of such
routine examinations tended to overwhelm the desire and the capacity
of the NASA medical staff to carry out limited examinations of
specifically targeted scope on those workers exposed to hazardous
conditions of work.
Members of the study subcommittee, representing several medical
specialties, reviewed materials submitted by NASA and met with medical
and industrial hygiene representatives of NASA to discuss past and
existing practices of medical surveillance and personal health
maintenance. In a series of meetings, the subcommittee then
considered NIOSH guidelines and other recommendations for appropriate
medical procedures. This report is the result of those deliberations.
I wish to express my deep gratitude to my distinguished colleagues
on the study subcommittee who contributed so generously of time and
effort in this task, and especially to llr. Leonard T. Kurland, who was
also a member of the parent Committee on Toxicology.
Members of the NRC staff were exceedingly helpful, including Gary
R. Keilson, Project llirector, whose background in the health sciences
proved invaluable.
James P. Hughes, M.D.
Chairman
Subcommittee to Evaluate NASA
Medical Surveillance Data Sheets
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^	 EXECUTIVE SUMMARY
The Committee on Toxicology (COT) of the National Research Council
Commission on Life Sciences was asked by the National Aeronautics and
Space Administration (NASA) to evaluate current rocedures used forp
preparing medical surveillance data sheets that are used by exariining
physicians at NASA. The data sheets contain information of vague to
the physician in determining possible consequence of exposure to
workr^lace chemicals.
The study, begun in December 1982, required the Formation of a
subcommittee of appropriate medical specialists in addition to members
of the COT and its staff.
The specific charge to the subcommittee was to assess the adequacy
of the current data sheets and suggest changes in design and content
if such modifications would improve the guidance offered to physicians.
The subcommittee, on reviewing procedures for developing medical
histories and ►nedical examinations, toxicity information and test
methods, concluded that:
1- Medical surveillance toxicity data sheets should be
authoritative and useful to a physician in predicting possible etfects
from exposure; they should be useful for making decisions about
periodic screening or for coping with overexposure; they should be
validated by experts.
2- NASA should develop a computerized medical-record-keeping systEm
for its employees which wo^^ld serve a variety of purposes.
3- Workers should be informed of potential hazards of materials
they are exposed to, encouraged to work safely, and keep informed of
results of medical tests.
4- Some follow-up examinations should be considered after
employment is terminated.
- vii -
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INTRODUCTION
Awareness of the potential adverse health effects of workplace
exposure co chemical and physical agents has been increasing in recent
years. According t^ the Environmental Protection Agency (EPA) and the
Natior,,^1 Institute for Occupational Safety and Health (NIOSH), some
45,000 chemicals and 250,000 formulated prod:^^ts are used
commercially. Some are known human toxicants, others have been shown
to be toxic to experimental animals. But few are wide; • subjected to
medical surveillance for adverse effects. The Occupational Safety and
Health Administration (OSHA) has promulgated health standards
requiring medical examination for workers exposed to any of 2.4
s^ibstances. NIOSH recommends medical screening for workers exposed to
any of 400 other substances. These recommendations are contained ir.
NIOSH criteria documents or were proposed in the NIOSHfOSHA Standards
Completion Project. Some employers provide periodic voluntary medical
examinations of exposed workers, and a few labor organizations endorse
these through the use of union-management health and welfare funds.
In recognition of potential occupational health hazards, the
National Aeronautics and Space Administration (NASA) has instituted
several health and safety programs for its employees. NASA was
established by Congress in 1958 as an independent civilian agency in
t}ie Executive Branch. Its headquarters are in Washington, D.C., and
it has 11 major field centers and several component installations.
About 23,000 NASA employees and about 30,000 conti^.ctor employees work
at the various installations.
NASA's health and safety programs vary in content and depth among
the installations, but the basic components include:
• Safety Program--Concerns provision of a safe work environment
and prevention of job-related accidents.
• ^ccupaticr.al Medicine Program--Includes job-related medical
examinations, health education, physical-fitness programs, screening
tests for specific diseases, and emergency treatment.
• Environmental Health Program--Includes identification oil
potential health hazards and implementatio^i of control measures to
minimize and prevent exposure.
NASA recently began to develop medical surveillance data sheets to
provide specific guidance to its occupationai physicians on chemical
and physical agents most often encountered in the workplace.
It has developed data sheets on 55 chemical and physical agents.
Initial drafts were prepared by a consultant in occupational medicine;
revisions were later prepared by NASA's medical staff.
NASA has asked the National Research Council (NRC) to assess the
procedures used to develop the data sheets and to suggest changes in
their design and content that would improve the guidance offered to
physicians. It has also asked for suggestions of ways to improve
collection, analysis, and management of mec^i.cal data. Administrative
responsibility for this task was assigned to the Committee on
Toxicology of the Board on Toxicology and Environmental Health
Hazards, in the NRC :,ommission on Life Sciences. The Committee
delegated primary responsibility for this task to the Subcommittee to
Evaluate NASA Medical Surveillance Data Sheets, consisting of expect
in occ^lpational medicine, epidemiology, clinical pathology,
toxicoloEy, and internal medicine.
The Subcommittee reviewed sample data sheets on asbestos,
4,4'-methylenebis ( 2-chloroaniline), dichlorofluoromethane,
formaldehyde, and hydrazines. 1t also was briefed by NASA officials
on the status of medical recordkeeping and future needs in that field.
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2GUIDELINES FOR GENERAL MEDICAL EXAMINATIONS--
PREPLACEMENT AND PERIODIC
NASA's guidelines for general medical examinations, as part of
preplacement screening and for periodic health examinations of those
already employed, provide for both personal health maintenance and
early detection of work-related abnormalities. Although this
comprehensive approach has merit, it tends to obscure the primary
mission of the ^^ccupational-health team: health effects of work
exposure to potentially hazardous agents. When a broader scope of
examinations for personal health maintenance is possible, recent
critical reviews (described below) of the efficacy of component
procedures should be considered.
PERIODIC EXAMINATICNS
The Canadian Tatik Force on the Periodic Health Examination (1979)
reviewed data regarding the mortality, morbidity, and disability
ascribable to 78 selected target conditions and evaluated the
potential efficacy of therapeutic interventions. The Task Force
grouped the interventions that were found to be efficacious into 18
health-protection measures to be performed at 35 specified times
between infancy a«d old age. These recommendations have become
important factors in modifying general attitudes to periodic health
examinations and guiding many physicians in their utilization of
medical history, physical examination, and laboratory tests. Breslow
and Somers (1977) described a similar set of periodic health
examinations and also suggested a large reduction in the amount of
routine screening of the .symptomatic population. Recent
recommendations on this subject have also been made by the Council on
Scientific Affairs of the American Medical Association (1983). The
AMA emphasized that periodic medical evaluation of healthy persons "is
important for early detection of disease and for the recognition of
certain risk factors that may presage disease." It concluded that the
Frequency of periodic examinations and the procedures employed will
vary, depending on such factors as age, heredity, occupation, and
socioeconomic status. Some general recommendations were provided on
the frequency of examinations and on test proced^ires to be performed.
None of these sets of recommendations, however, specifically took
into account the special demands placed ,,n an agency attempting both
to safeguard the health of its workers and to establish a baseline for
determination of the impact of hazardous exposure. Although the
Subcommittee accepts [he general principles of the Canadian Task Force
and others, the sc^^pe of the preplacement and periodic examinations
should be expanded to include factors of occupational significance.
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PREPLACEMENT EXAMINATIONS
Unlike general examinations fo ►• screening the population at large,
preplacement screening for NASA should e^tablisli a clear baseline with
regard to potential hazard for the employee. The history taken at
initial examination should include a detailed account of the person's
medical, family, social, and occupational history, as well as a
comprehensive review of organ systems. The occupational history
should include documentation of exposure to workplace
hazards--physical, environmental, and chemical exposures. In
particular, if the position in NASA for which the aF^licont is being
screened includes exposures to similar occupational hazard, efforts
should be made to obtain occu pational-health data from the place of
employment where the prior exposure took place.
The preplacement examination should include the remainder of a
complete physical examination, including examination of head, scalp,
eyes, ears, nose and t}ir^at, chest and Dings, heart, abdomen,
genitalia, rectum, extremities, and skin; neurologic
examination--assessment of motor strength of biceps, triceps, grip,
and quadriceps; sensory evaluation for vibration, pin, and light
t+^^ich; deep tendon reflexes of t}ie hrachioradialis, quadriceps, and
achilles; assessment of the plantar response; analysis of cranial
nerve function; and mental status assessment with standardized brief
cognitive-function testing. At the University of Washington, a
55-step screening physical examination has been developed that can be
cc^npleted by a skilled occupational-health person in a short period.
For health maintenance, recommendatic+.ts of the American Medical
Association and the Canadian Task Force on immunizations and general
health counseling should be considered.
Hypothetically, the physician may be able [o detect--through
medical histories, physical examinations, and laboratory studies--a
subset of the population that is a[ higher risk or [ha[ presents a
risk [c others by virtue of an existing disease or a predisposition [o
disease or injury. Examples are a day-care worker with tuberculosis
and a pe rson with a seizure disorder who works with machinery.
Some workers are also excluded from employment because
hypersusceptibilit y
 to disease or injury is presumed on the hasis of
inappropriate tests or misinterpretation of results. For example,
routine preplacement radiography of the l^imbar spine is still
practiced in some industries with a tendency to exclude from many jobs
applicants with even minor congenital vertebral variations. There is
a lack of evidence that such intervention is effective in preventing
back injuries. Given the lack of c^>nsensus of what constitutes
hypersusceptibility in workers, the occupational physician should
avoid exclusionary policies that are no[ clearly effective in
preventing disease ur inj^iry.
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LABORATORY INVESTIGATIONS
Laboratory studies should be limited to those relevant to anticipated
exposure to potentially toxic agents. Recommendations of the Canadian
Task Force and others should be tempered by the need to select tests
that can identify wor}<ers who will be particularly susceptible to the
effects of hazardo^is exposure, e.g., decreased hearing in a worker who
may be exposed to loud noise.
In contrast with the preplacement general examination, the
periodic health examination should focus on the detection of
conditions that, although they may not be treatable, wo •• ld provide
data useful in improving preventive strategies for other workers
exposed to the_ same hazard. Th y
 choice of laboratory tests for the
periodic examination must be tailored to t}^e exposure to avoid
generating excessive false-positive results while maintaining
sufficient sensitivity to detect abnormalities that are truly
attributable to the occupational exposure. Emphasis should be on 	 }
identification of laboratory or physical abnormalities with an eye to
direct intervention for specific workers or to improvement in
preventive strategies in the workplace. Operational or placement
decisions that flow from clinical or laboratory examinations and
interpretations must have objective bases. The placemN^it or
nonplacement of a person for }iealth reasons must be grounded in fact
rather than speculation. Administrative decisions that ar^^
unsupported by medical evidence but claim "medical" bases have been a
source of harm and litigation.
- 5 -
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GUIDELINES FOR POTENTIALLY HAZARDOUS AGE":TS
In addition to general preplacement and periodic medical examinations,
NASA provides medical surveillance targeted to specific hazards in the
workplace. The Subcommittee believes that the primary focus of the
occupational-health team must be on the identification and control of
potential health risks in the workplace. The occupational physician
commonly faces a worksite with many potentially hazardous agents, few
of which may be well known for their toxic -roperties and for fewer of
which biologic monitoring and medical examination techniques are
performed. The occupational physician usually depends on the
industrial hygienist to identify and quantify these potential
hazardous agents in the workplace, to evaluate the adequacy of
engineering control measures, to test workers' personal environment to
ensure that exposures are within acceptable limits, and sometimes to
suggest analysis of body fluids (biologic monitoring) for evidence of
absorption.
As a secondary defense, the occupational physician may examine and
question workers for early signs or symptoms of disease, in addition
to interpreting the results of biologic monitoring and perhaps
providing other clinical laboratory tests. In this context, a worker
with evidence of occupational disease represents a failure of primary
prevention. In circumstances in which toxicity is not suspected,
occupational disease .nay suggest the presence of a nonsuspected
toxicant in the workplace. In either case, information on observed
human harm not only must be used for the benefit of individual
workers, but must be provided to those practicing primary
prevention--the safety engineer and the industrial hygienist--with the
goal of further control of exposurF^.
The medical surveillance data sheets developed by NASA provide to
[he occupational-health team valuable background and toxicity
information on potentially hazardous agents and guidance on medical
surveillance. This chapter, based on a review of a selected sample of
WASA medical surveillance data sheets, is intended to guide NASA in
futher development of such sheets. The major section headings
generally follow the outline currently used in tl^e data sheets and
could serve as a useful format.
BACKGROUND INFORMATION
Physicians and other occupational-health practitioners are not likely
to be familiar with the potential adverse health effects of many of
[he physical and chemical agents encountered in the workplace.
Detailed knowledge of specific materials varies considerably, so it is
best to assume that users of medical surveillance c'ata sheets have
only a limited familiarity.
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The data sheets that have been prepared by the NASA medical staff
are revisions of earlier drafts; all comments in this section are
directed toward these revised data sheets. The background information
is well organized, clearly presented, and adequately referenced. Ttie
following are offered as suggestions for incorporation into the data
sheets.
SYNONYMS AND TRADE NAMES
It appears that s^ifficient information has been compiled, and no
changes are suggested.
PHYSICAL FORM
This section should be expanded to include physical and chemical
properties. A statement concerning the physical form of the maters:+1
is helpful, but other information, such as molecular weigh[, chemical
formula, chemical structure, boiling point, melting point, solubility,
and vapor pressure would be useful to the reader.
EXPOSURE LEVELS
Exposure levels should be presented so that the terminology is clear,
the applicability of the values is well understood, and differences in
recommendations among agencies are explained. For example, the OSHA,
NIOSH, and American Cociference of Governmental Industrial Hygienists
(ACGIH) recommendations for man' materials differ. A brief
explanation would give the reader a better understanding of the basis
for the differences. The date when a given value was established
should also be shown, so that the reader is aware of the currency of
the information. Tr.e ^inits for expressing airborne concentration
should be consistent, so that comparisons can be readily made. Where
applicable, concentrations of chemical agents should be expressed in
both parts per million (ppm) and milligrams per cubic meter
(mg/m3). It also would be helpful to include the definitions of the
OSHA and NIOSH permissible exposure levels, the ACGIH threshold limit
values, and any other terms used by these groups.
EXPOSURE ROUTE
Information on the routes of entry into the body is important in
suggesting the likely extent of exposure and what organs might be
affected. In addition to the exposure routes, it would be helpful to
state which are the most important routes and the likelit;^^od of
exposure by each route. For example, if skin is a possible exposure
route, some information should be given on the likely extent of
absorption and penetration of the material.
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USES AND INCOMPATIBILI'CIES
Ti^ese sections provide information on the mayor uses of the agent and
on materials that, if they are present with the agent, could p-oduce a
potentially hazardous situation. For example, formaldehyde is
incompatible with strong oxidizers, strong alkalies, acids, phencls,
and urea. These sections are self-explanatory; no additional
suggestions are offered.
TOXICITY INFORMATION
Two drafts of the sample data sheets were reviewed by the
S^ihcommittee. In the first, the toxicity information was terse:y
summarized in a two- or three-sentence statement under the heading
"Toxicity." The advantage of this approach is that the statement fits
into the tightly structured outline of the entire data sheet; the
disadvantage is that the capsular information does not provide
sufficient guidance to NASA physicians. In the set of second drafts,
the [oxicity information was put forth in a loosely structured
narrative under the heading "Toxicology and Medical Aspects." The
toxicology section comprised three to six paragraphs of text and
approximately a dozen bibliographic citations. The advantage of this
approach is that the narratives provide more of the information that
NASA physicians need for medical surveillance of workers who are
exposed to t}ie various substances; the disadvantage is th.it the
narratives are not as authoritative as the comparable sections in
standard texts of industrial toxicology (e.g., Proctor and Hughes,
1978; Finkel, 1983; Clayton and Clayton, 1981; Rom, 1982).
In the Subcommittee ' s opinion, the toxicity sections of tl^e ^^ASA
medical surveillance data sheets should conform to the semioutiine
format characteristic of the other sections; they should supplement,
rather than substitute for, standard texts, monographs, and criteria
documents. ( In those instances where other reviews are not available,
the data sheets would need to be more comprehensive). To summarize
the pertinent toxicologic data for NASA physicians in the most
accessible fashion, the toxicity sections might be patterned on tl^e
familiar exa,nple of a medical case history. Whereas textbooks seldom
include negative toxicity data, reliable information on the absence of
toxicity in man and animals is important to NASA physicians.
Therefore, like medical case histories, the NASA data sheets should
aim for emphasis on positive and negative observations that might be
related to exposures in the workplace. It would also be helpful to
indicate where there are a lack of studies in critical areas. The
length of the toxicity sections of the data sheets may vary widely,
depending on the clinical substance in q^iestion, but there should be
no hesitancy to refer. to texts, r^ionographs, and criteria documents for
additional data and background information.
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The following general outline is proposed for the toxicity section
of the NASA medical surveillance data sheets:
• Abstract. This section, analogous to the list of "chief
complaints" in a medical case history, should concisely itemize the
major toxic hazards of the chemical substance in the workplace.
e Toxic Effects on Humans. This section should tabulate the toxic
effects that occur in humans after acute or chronic exposures to the
substance. If neither acute nor chronic effects of human exposures
have been reported, the extent and reliability of the negative
clinical data should be stated. The genetic, life-style,
pharmacologic, or environmental factors that may influence human
susceptibility to toxic effects of the substance should be mentioned.
o Epidemiologic Studies. This section should provide a synopsis
of epidemiologic studies of human exposures to the substance, with
particular attention to (a) the incidences of neoplastic, respiratory,
cardiovascular, neurologic, reproductive, dermatologic, and allergic
disorders in exposed workers and (b) correlations between exposure
levels and specific incidence rates.
• Toxic Effects in Animals. This section should suamarize (a)
absorption, transport, distribution, metabolism, conjugation,
deposition, and excretion, (b) LD50 values of the substance in
experimental animals by various routes and dosage schedules, (c)
characteristics of t;ie toxic responses, (d) pathologic lesions in
target tissues, (e) cellular and molecular mechanisms of toxicity,
(f) correlation between dosage levels and toxic effects, and (g)
evidence of synergism or potentiation by combined exposure to the
substance and other chemical or environmental factors.
• Carcinogenicity, Mutagenicity, Teratogenicity, and Reproductive
Effects. This section should sumr:arize experimental data on genotoxic
effects of the substance in animals, tissue-culture cells, and
microorganisms. If carcinogenicity of Lhe substance has been
evaluated in an International Agenc- , for Research on Cancer (TARC)
monograph, the TARC conclusions regarding the evidence of
carcinogenicity should be stated.
Sci?ntific Literature. In addition to the customary
bibliography of cited articles, this section should speci.y whether
the substance has been considered in a monograph or criteria document
by such a group as NIOSH, OSHA, EPA, ACGIH, she National Academy of
Sciences - National Research Council (NAS-NRC), the World Health
Organization (WHO), or the Commission of the European Communities
(CEC). Criteria documents fr.)m the other countries, such as Great
Britain, Canada, Scandinavia, and Japan, should be included, as well
as reference volumes on the substance and authoritative discussions in
textbooks.
The toxicity section of each NASA medical surveillance data sheet
should be updated by NASA staff every 2 or 3 years, and reviewed by
persons thoroughly acquainted with the clinical and toxicologic
literature on the relevant class of chemical substances. The names of
the reviewers and the date of the review should be stated on each data
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sheet. Pertinent new information should be inserted into the data
sheets by NASA staff as it becomes available; such new information
should be identified as an addendum to the preceding version of the
document. More detailed comments on possible review mechanisms are
provided in Chapter 5.
EXPOSURE HISTORY
PREPLACEMENT EXAMINATION
The goals of the preplacement examination are to avoid placement of
workers in jobs to which they are unsuited for health reasons, to
gather baseline information to assess the impact of later absorption
of toxicants or resulting pathologic conditions, and to detect ill
health that may have resulted from exposure.
The exposure history should be complete. If the employee is not
certain about prior exposures, past employers should be queried. In
view of the uncertainty of such exposure histories, documentation
should be sought whenever possible.
If the effort to establish the exposure history is exhaustive, the
occupational physician will be confronted with a multitude of chemical
exposures. The assistance of industrial hygienists, toxicologists,
and others may have to he sought to review the health implications of
the exposures. The scope and detail of the preplacement examination
should reflect prior exposures.
The occupational physician should know the specific risks of the
particular jobs to which employees are to be assigned. For each
hazard, the medical data sheet prepared with expert guidance will be
needed to establish the appropriate baseline examinations and to
establish which predisposing health conditions should contraindicate
particular placements.
PERIODIC EXAMINATION
The goals of the periodic examination are to detect evidence of
absorption of industrial toxicants, to detect early signs or symptoms
of disease, to detect changes in the health of the employee since the
preplacement examination that may require a change in job placerienr,
and to provide data for the reevaluation of the plant's control of
exposure. The occupational physician should depend on the employee
and the industrial hygienist for a detailed inventory of job
exposures. For each such exposure, there should be available for the
physician a review of adverse health effects, contraindicated
preexisting health conditions, and specified components of the history
or physical examination effective in detecting pathologic conditions.
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OVEREXPOSURE
For effective handling of accidental exposure, the nature of the
chemicals involved in the exposure must be known and appropriate
interven,ion mast have been planned. The time of the exposure is not
the appropriate time for research on the chemical constituents of a
commercial product and for developing recommendations as to therapy.
Hence, just as the occupational physician must be provided with
details of specific exposure to guide the periodic examination, this
information and detailed instructions on therapy must be available at
t%c time of accidental exposure.
EXPOSURE HISTORY AT TERMINATION
At the termination examination, the exposure history since the
previous periodic examination should be updated.
MEDICAL HISTORY AND PHYSICAL EXAMINATION
The preceding section on exposure history emphasizes that a detailed
assessment of past exposures is necessary for appropriate placement of
the employee and for guidance of the physician on laboratory tests,
specific historical questions, and physical signs to look for. For
each exposure, there needs to be a detailed review of potential
adver.;e reactions, methods for early detection of pathologic
conditions, predisposing conditions, etc. This review will determine
the specific auestions and signs to be selected in the clinical
examination.
Standard sources that are available and will be of some value in
this effort include the NIOSH criteria documents and Chemical Hazards
of the Workplace (Proctor and Hughes); the latter is a reflection of a
NIOSH/OSHA standards completion project. The recommendations
contained in those sources, in general, need review by experts,
because their basis is not always apparent.
The selection of history and physical examinations should be
guided by basic precepts. The following precepts constittite a
modification of priacip?es originally suggested by Wilson and Junger
(1968) for screening in the community. Examples are drawn primarily
from the draft NASA medical surveillance data sheets for MOCA (4,4'-
methylenebis(2-chloroaniline) and asbestos.
CHARACTERISTICS OF THE SCREENING TEST
1. There should be a suitable test system or examination and
qualified personnel to interpret results. For example, chest x rays
of asbestos-exposed workers should be read by B readers proficient in
the diagnosis of occupational respiratory disease.
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2. The tests iced not be simple, as they must be for screening tests
in the community. For example, assaying urine for MOCA or abnormal
urinary cytology may yield appropriate early warnings of absorption or
adverse effects and may be valuable as screening tests. However,
neither is simple or inexpensive.
3. The screening test should be effective (with respect to
sensitivity, s ,,ecificity, and predictive value) for the _population and
the specific exposure. For example, a chest x ray of an
asbestos-exposed worker is unlikely to detect abnormality in the first
decade of exposure and hence is an insensitive early measure of hazard
or effect.
4. Risks inherent in the screening test should be weighed against
possible benefit. For example, the value of a chest x ray of an
asbestos-exposed person in the first decade of exposure should be
weighed against the adverse affect of the radiation..
5. The screening test should be targeted to the specific risks of the
exposed population. For example, MOCA is not known to be a lung
carcinogen, so sputum cytology analysis does not seem related to the
effect of the exposure.
6. The screening test should be acceptable to the population. Some
workers may see questions concerning family history of cancer or
menstrual history as unnecessary invasions of privacy unless a clear
relationship to MOCA-associated disease can be shown. The employee
Fopulation should also be informed of the relationship between the
hazard being screened for and the test.
CHARACTERISTICS OF THE DISEASE TO BE SCREENED FOR
7. The condition screened for should be important to the individual
or the community. At the extremes, fatal diseases, such as lung
cancer, are clearly important, whereas some manifestations of chronic
tral,ma, such as writer's callus, are less important. Between these
extremes, the importance of a disease either in the individual or in
the community is a matter of judgment.
8. There should be an accepted treatment for patients with recognized
cases of the disease screened for, or the screening data should be
useful in improving prevention in other workers similarly exposed. In
the community, lung cancer would not be sought through screening,
because earlier diagnosis and therapy world be of little added value. 	 j
However, a lung cancer in the workplace can indicate excessive 	 ( '
exposure. Screening for nontreatable di p aase is appropriate in the
workplace if the data generated will be taken as a reflection of the
adequacy of protection of other workers who are similarly exposed.
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9. The disease screened for should be detectable during a latent or
asvmptomatic stage. For example, through urinary cytology, it may })e
possible to detect a bladder cancer before symptoms appear. However,
if a disease can he detected only at the time of usual clinical
examination prompted by the onset of symptoms, there is no role for
screening.
10. The natural history of the disease screened for, including
development from latency to manifestations, should be adequately
understood. For example, the frequency of chest x rays to detect
asbestos-associated cancer should depend on the length of the
presymptomatic stage of the disease. Without an understanding of the
natural course of the disease, the timing of screening t p srs is
guesswork.
11. There should be a policv on the abnormal test results that would
prompt action. Many tests will have a continuum of results. Whether
these tests are unusual (e.g., urinary `IOCA) or more common (e.g.,
liver function), guidelines should be offered to the occupational
physician on what action to take for specified degrees of abnormality.
CHARACTERISTICS OF THE WORKPLACE DISEASE-PREVENTION PROGRAM
12. Other methods for primary prevention of occupational disease
should already be in use when a medical screening program is proposed.
The prevention of occupational disease depends on a continuation of
measures that include chemical selection, premarket testing,
substitution, engineering controls, environmental monitoring, personal
protective devices as masks and gloves, biologic monitoring for the
absorption of a toxicant or its metabolite, medical screening, and
clinical care. Medical screening is a secondary means of prevention,
inasmuch as the disease process has already been initiated.
13. Facilities for diagnosis or treatment should be available, as well
a ,; co,inseling and other support services for cases of nontreatahle
disease. Screening programs generate information that is of
importance to individual workers. Before screening is instituted,
there should be plans for caring for workers with true or
false-positive results, which are inevitable in a screening program.
14. The dual purposes of screening programs--individual diagnosis and
worker-population assessment--should be reco gnized and s pecified for
each program wto-i it is undertaken. When the goal is assessment of
the health status of the worker population, the screening data should
be analyzed epidemiologically.
The substance of the history and physical examination is
influenced by the nature of past, current, and potential exposures.
The preplacement examination provides a baseline for evaluation of
past exposures and evaluation of the suitability of a worker for
exposures to br encountered in the new work situation. The periodic
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examination helps in evaluating the effects of exposures in the
immediately preceding work period and the long-term effects of earlier
exposures. The frequency of evaluation of the effects of past
exposure should be based on knowledge of the natural history of the
disease processes. These followup examinations need not be done at
every regularly scheduled periodic examination. In giving a history,
the patient should be queried about illness that may have developed
and resolved between periodic examinations. For example, the
occupational physician looking for cancer of the skin may find none on
examination, but may find that the patient has had a tumor diagnosed
and Qxcised by a personal physician in the interim between periodic
examinations. Finally, the termination physical should include a
comprehensive evaluation of all effects of past exposures since the
last periodic examination.
LABORATORY TESTS
Wilson and Jungner (1968) deve l opeu a set of principles for screening
for disease that apply to periodic health surveillance of apparently
healthy people, but do not apply in every particular to medical
screening in industry for workplace hazards, as pointed out by
Halperin et al. (1982). In addition to detection of significant and
treatable disease, screening for workplace hazards must detect hazards
that may be prevented by minimizing further exposure of those tested
and their co-workers. In population screening, simple inexpensive
tests are desirable; but in screening for occupational hazard, the
most effective test should be used.
In selecting laboratory tests for screening, important test
characteristics should be taken into account (Galen and Gambino,
1975), such as diagnostic sensitivity, diagnostic specificity, and
positive and negative predictive values. Diagnostic sensitivity is
the ratio of true positives--the number of persons with the condition
sought who yield a positive test result to the number of persons
tested who have the condition sought. It answers the question: "What
is the likelihood that a patient with a given condition will have a
positive test result?" Diagnostic specificity is the ratio of true
negatives--patients without the condition sought who yield a negative
test result to the number of persons tested who are free of the
condition sought. It answers the question: "What is the likelihood
that a person without a given condition will yield a negative result?"
While considerations of diagnostic sensitivity and specificity are
important for test selection, they are not the values that are helpful
in analyzing a test result. In this process, one wishes to know the
probability that a given positive test result indicates that disease
and the probability that a given negative test result excludes
disease. These probabilities are known as the predictive values of a
positive and negative test result. The predictive value of a positive
test is defined as the percent.ge of positive test results that are
true positives when the test is applied to a population of subjects
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which includes individuals with and without the disease being sought.
The predictive value of a negative test is the percentage of negative
tests that are true negatives under the same circumstances as
described for positive tests. Both of these values depend not only on
the diagnostic sensitivity and specificity of the test, but also
heavily on the prevalence of the disease sought in the population
tested.
If a test were perfect, it would be positive only in persons who
have a disorder resulting from the hazardous agent under consideration
and negative in all persons without any injury due to the hazardous
agent. Few tests in reality give such a good result. In general,
there is a considerable overlap of injured persons and those without
any impairment due to the injurious agent. This overlap of those with
and without iiijury presents a problem in screening. It is important
to use judg:..•_nt oad care in picking a cutoff point between those
judged normal and those judged abnormal. For example, if one is
considering an agent potentially injurious to the liver, one might use
serum gamma-glutamyltransferase (GGT) activity to monitor potential
hepatotoxicity. An increase in GGT activity would be a sign of liver
injury. In using the test, one might examine 25 normal people and 25
people with liver injury. A frequency distribution of results could
than be plotted, and a biphasic curve noted (see Figure 1). A high
cutoff point between normal and abnormal might be chosen if one wanted
to diagnose the condition of "liver toxicity" with assurance (high
diagnostic specificity). Ali appreciable number of cases of liver
toxicity would be missed tinder these circumstances but scarcely any
normal persons would be included in t'he abnormal group. If the cutoff
point were so low as to rule out the presen(.e of liver toxicity in the
normal group, an appreciable number cf normals (false-positives) would
be included in the liver-toxicity group. Unless further tests were
done to separate normals and abnormals further in the toxicity group,
many normal persons might be excluded from the workplace without
justification. It is usual in screening to attempt to "rul? out"
disease, so the cutoff point selected is usually low.
One of the better ways to choose a cutoff point is that proposed
by McNeil et al. (1975), the so-called receiver-operator-
characterist = c (ROC) curve (see Figure 2). In this construction, the
true-positive ratio is plotted against the false-positive ratio for
the test. Cutoff points to meet the needs of a particular testing
situation can be easily selected on the basis of such graphs.
Sunderman (1970) has pointed out that increasing the number of
tests increases the number of abnormal results found in a normal,
healthy person (see Figure 3). For this reason, it is important to
target tests well, so as to avoid many false-positive results when the
tests are used to detect health problems related to the workplace.
The specific hazards should be known and the tests targeted to them
and their toxic consequences.
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Review of sample NASA medical surveillance data sheets suggest
that test procedures recommended in them often lack desirable
sensitivity and specificity and are not targeted to consider the
toxicity of each agent. The Subcommittee has pointed out some
desirable characteristics of screening tests and precepts that should
guide their selection and implementation. It recormnends that the
laboratory tests identified in the NASA data sheets be thoroughly
analyzed by persons fully conversant with the toxic properties of
specific agents for consistency with the principles described above
and with promulgated OSHA standards. Detailed comments on review
mechanisms suggested by the Subcommittee are provided in Chapter S.
WORKER EDUCATION
The goal of worker education is twofold: to enlist the cooperation of
the worker in the proper landling of industrial hazards and, to alert
the worker to the early signs and symptoms of exposure so that
diseases can be detected as early as possible. Just as a prescribing
physician will offer to a patient a fact sheet on how to take a
medicine and on its adverse reactions or side etlects, so should
workers be informed on occupational hazards they encounter.
Information on the interaction of personal habits (such as smoking and
consumption of alcoholic beverages) with occupational hazards should
be provided. Particular attention should be paid to the termination
examination. Many occupational diseases have long latent periods, so
an ordinary history and physical examination in no way ensure that
disease will not occur after termination of employment.
Employees should be educated on the s pecific nature of
occupational diseases so that, if one occurs, it can be appropriately
diagnosed, treated, and reported.
information from medical surveillance testing and environmental
monitoring should also be provided to employees. The need to know the
agents '% which one is exposed is sometimes in contlict with corporate
needs to protect trade secrets. When it is legally impossible to
inform workers fully of their exposures, they should at least b y fully
informed of the potential adverse consequences of exposure.
The capacity of workers to understand and act on complex
information should not be underestimated. They should know the nature
of the hazards they encounter, should be advised on how to minimize
injury and illness through such measures as containwent and sale
handling, and should be informed about possible adverse health
effects. Once informed, the workers may well play a valuable role in
disease prevention.
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4NASA HEALTH INFORMATION SYSTEM--ASSESSMENT OF CURRENT
SYSTEM AND RECOMMENDATIONS FOR THE FUTURE
NASA is involved in the development and implementation of a broad
health surveillance system and a uniform health information system
that will be applicable to its administrative, scientific, and other
employees at the various space centers. Of particular concern in this
connection are employees who work in environments with known or
potential exposures to hazardous chemical, physical, or biologic
agents. Preplacement medical examinations, as well as periodic and
episodic health surveillance procedures, are provided as stipulated by
OSHA or as indicated in the opinion of the large staff of contract
physicians, nurses, industrial hygienists, etc., concerned with
occupational health and environmental protection at the space centers.
The Subcommittee's task was primarilv to aid'NASA in the
development of medical surveillance data sheets on some 55 agents for
which there is potential rxposure•in the workplace. Although the
emphasis was on the design and adequacy of the medical history,
phvsical examinations, laboratory tests, and toxicit y
 information
contained in the data sheets, the Subcommittee believed it was also
necessary to evaluate health surveillance procedures in general and to
provide guidance for the local centers and a central health
information system.
Currently, NASA conducts preplacement and periodic examinations
and monitors and records exposure levels for various agents. If
action levels are reached, further medical information is obtained.
As part of the examinations, certain items of medical history and
laboratory tests are specified. Laboratory findings outside normal
limits are recorded, as are clinical impressions and diagnoses. No
private physicians's input on job-related or non-job-related events is
required or collected. Retired personnel are not routinely followed,
nor is information from death certificates and autopsy reports
routinely collected.
Information is collected and filed in separate local NASA
facilities and rarely serves as a basis for systematic review of
possible toxic effects or preventive practices or even for reassurance
as to the absence of toxic effects. On occasion, exposure levels and
examination results have been compared, but only with considerable
effort and time. Although various industries, elements of the
Department of Defense, and perhaps individual NASA contractors are
concerned with efforts to provide information on health and
occupational exposures, there is little linkage or sharing of
information among these entities.
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When one considers the substantial cost of health maintenance and
occupational-health surveillance, it is unfortunate that the
relatively small additional amount necessary for data collection,
storage, linkage, and analysis is not available. Such treatment of the
data could benefit employees and further toxicologic and epidemiologic
knowledge. What is needed is a standardized system for all NASA
units, covering event coding structures; inclusion rules; occupational
classification (with specifications of hazardous exposures); the
linkage of results of preplacement and periodic examinations with
exposure data, diagnoses made during emergency and ambulatory care,
and summaries of inpatient care; and periodic followup, with death
certification and, when available, autopsy diagnoses. Recent reviews
on medical recordkeeping as a resource for clinical care and for
epidemiologic investigations (Kurland and Molgaard, 1981) and on the
state of the art of occupational-health information systems (Finucane
and McDonagh, 1982) are available.
Bringing together the elements described above as a standardized
health information system throughout NASA can contribute to the
following:
• Improved health maintenance of NASA personnel.
• Improved personal health services of NASA personnel.
• Improved recognition of the short- and long-term effects of
exposure to known and unsuspected physical and chemical agents.
• Improved health planning and improved use of medical and
industrial-hygiene personnel and programs.
• Improved clinical and epidemiologic research as a result of the
proposed record linkage.
The Subcommittee suggests that NASA develop a population-based
health-information system, in a standardized format, that will provide
a longitudinal health and safety record on NASA employees. This
system would combine health information collected throughout and after
NASA employment, as well as occupational and environmental monitoring
during employment. The system should enroll personnel at the time of
employment, include data from a baseline health asssessment and
occupational history, include diagnostic and procedure information
from ambulatory and inpatient services, and provide followup
information, including time, place, and cause of death. This system
should he standardized to provide information linkage between
worksites and the locations at which medical care is received.
The following must be known if the goals referred to above are to
he met:
• The demographic characteristics of the NASA popul.ation--age,
sex, race, worksite, and tasks.
• Background exposur- levels and episodic variations in exposure.
• Health-care ;exults (clinical and laboratory findings), with
emphasis on diagnosis as indexed in a system like the International
Classification of Diseases, 9th Revision, Clinical Modification
(ICU-9-CM).
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• Information on medical and surgical problems; time, place, and
cause of death; and postmortem findings obtained from followup
throughout employment and, where feasible, after employment from
periodic mail inquiry.
The proposed unified health-information system should have the
following features:
O The system should be population-based, with enrollment of
eligible personnel at the time of employment (or, for current
employees, at the time of activation of this program). This will make
possible the comparison of various occupational and other groups with
respect to health status. If epidemiologic studies are to be
conducted, they must be based on valid denominator information.
• The system should record occupational status and specific
exposures in a standardized manner.
e Event coding should be standardized for diagnoses and surgical
procedures and should use such disease classifications as ICD-9-CM;
pathology coding could also use ICD-9-CM, although SNOMED (Standard
Nomenclature of Medicine) should be considered. Immunizations and
prescribed drug coding with standardized pharmaceutical numbers would
be desirable for recognition of short- and long- term adverse effects
of drugs, as well as of the potential of some drugs to confound
toxicologic studios.
• The system should be suitable for employees' personal health
care, as well as job-related events. If it is feasible, information
should be sought especially from long-term employees who leave for
health reasons or retirement; however, complexities in the private
health-care sector may act to limit such information as that on time
and cause of death.
• The data entry and storage system should be computerized and
should use a record format that can be partially self-administered,
but that is user-friendly and well tested.
• The concept of basic and optional data sets should be built into
the system to maximize utility and flexibility. The basic system
should include standardized registration and enrollment information,
standardized event coding, and a standardized set of items--e.g.
occupational status, health problems or complaints, diagnoses, and
treatments. Optional features might include information particularly
relevant to a particular worksite, group of personnel, or study
situation.
• Because information must be collected from various
administrative units--including health, personnel, and work
units--such units should be represented in discussions designed to
plan the system.
• If the plan is to be adopted, feasibility studies directed at
the attainment of the specified goals are recommended. Exchange of
information with the private medical-care sector, including
health-maintenance organization (HMO) facilities and the military
services, is desirable.
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CONCLUSIONS AND RECOMMENDATIONS
The Subcommittee believes that a program to develop a series of
medical surveillance data sheets for use by NASA physicians should
have two goals: to present concise summaries of current information on
the toxicity and health hazards of chemical, physical, and biologic
agents that are of relevance to NASA and to provide specific
guidelines regarding medical surveillance of exposed workers. These
data sheets should reflect the leading edge of knowledge and practice
in occupational medicine, presenting authoritative and up-to-date
treatment of each agent in a capsule format. In meeting these
objectives, the data sheets should not supplant standard texts, such
as those available on industrial toxicology and occupational medicine.
The two sets of NASA medical data sheets reviewed by the
Subcommittee meet these objectives to a large extent. The
Subcommittee found aspects of both sets of drafts useful, and with
some modifications these will be of immense value to NASA's
occupational physicians. The following recommendations are offered to
improve the quality of the individual data sheets and the guidance to
physicians. More general comments are also offered on NASA's overall
occupational-medicine program.
BASIC PRINCIPLES
It is important to identify a set of basic principles that will guide
NASA's occupational-medicine program and, more specifically, guide the
program in developing medical surveillance data sheets. Chapter 2
discusses the most recent reviews on the concepts related to general
preplacement and periodic medical examinations. Chapter 3 suggests a
set of principles for medical history and physical examinations,
worker education, and laboratory investigations targeted to
potentially hazardous agents.
GENERAL MEDICAL EXAMINATIONS
The procedures used by NASA for general medical examinations--both
preplacement screening and periodic health examinations--were selected
in an effort to provide for both personal health maintenance and early
detection of work-related abnormalities. This approach has merit, and
its goals are commendable. However, the Subcommittee believes that it
tends to obscure the primary mission of the occupational-health
team--to focus on the health effects of workplace exposure to
potentially hazardous agents. When the broader scope of personal
health maintenance examination is offered, the principles and issues
identified in Chapter 2 should be considered.
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GUIDELINES FOR SPECIFIC EXPOSURES
On the basis of its review, the Subcommittee offers the following
suggestions with regard to the basic components of medical
surveillance data sheets.
BACKGROUND INFORMATION
Although physicians are likely to have knowledge of some workplace
hazards, most physicians are not likely to be thoroughly familiar with
all potential hazards in the NASA workplace environment. Therefore,
background information--such as that on uses, physical and chemical
properties, and exposure--needs to be sufficiently addressed. Chapter
3 suggests types of information that should be included in the medical
data sheets.
TOXICITY INFORMATION
The Subcommittee believes that the toxicity information in the
medical data sheets should be presented in outline form, rather than
narrative form, and patterned after a medical case history. The
information should be authoritative, but not exhaustive; the objective
is not to replace standard texts in the field. The information should
be referenced and reflect up-to-date knowledge. The Subcommittee
suggests an outline of this section in Chapter 3.
EXPOSURE HISTORY
Exposure histories should be complete and provide enough
information to guide the occupational physician in assessing pos:,ble
health risks associated with particular job assignments, in conducting
periodic physical examinations, and in dealing effectively with
accidental overexposures (appropriate interventions should be
planned). The assistance of representatives of other
specialties--such as toxicology, industrial hygiene, and safety
engineering--will be needed to assess adequately the imp l ications of
particular exposures.
MEDICAL HISTORY AND PHYSICAL EXAMINATION
The Subcommittee has identified in Chapter 3 basic precepts that
should guide the taking of medical histories and the performance of
physical examinations. In particular, the Subcommittee believes that
certain characteristics of screening tests, diseases to be screened,
and workplace disease prevention programs should be considered.
Examples of these characteristics are provided in Chapter 3.
LABORATORY INVESTIGATIONS
The Subcommittee found that many of the laboratory tests
recommended in the sample NASA medical surveillance data sheets are
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not in accord with basic principles for laboratory screening for
disease. For any test, sensitivity, specificity, and positive and
negative predictive values should be clearly understood. Each test
should be carefully examined for its predictive value before it is
recommended. Increasing the number of tests performed increases the
likelihood of finding abnormal results in a healthy person. It is
important to target the tests to avoid false-positives. Laboratory
tests targeted to a particular agent should be recommended only after
careful consideration of the principles described in detail in Chapter
3 and only by individuals fully conversant with the properties of the
agent.
PREPARATION AND REVIEW OF MEDICAL DATA SHEETS
Information is constantly being generated in the field of occupational
medicine. It is imperative that NASA develop a schedule for update
and revision of the data sheets. The subcommittee believes that
ideally the data sheets would be updated every 2 or 3 years.
To be accepted by NASA's phy;.icians, the information provided in
the data sheets must be authoritative. Peer review of the data sheets
before they are sent to ,physicians is essential. Ideally, to ensure
quality, each data sheet would be prepared by toxicologists,
physicians, and others whc are thoroughly familiar with the literature
on the agent in question.
Several governmen.: agencies and other organizations have
instituted peer-review systems to assist in the preparation of
technical documents; such a system should be instituted by NASA. The
Subcommittee recognizes that establishment of a separate panel for
each data sheet would likely be too cumbersome and difficult to do,
both logistically and financiall y . It is recommended that panels
instead be formed for classes of hazards. Each panel would consist of
members of the scientific community selected for their competence in
fields relevant to an assessment of the medical data sheets, such as
toxicology, occupational medicine, clinical pathology, and clinical
medicine.
Several possibilites are available with regard to the location of
the review panels. NASA can establish its own expert panels, with
appointment of members being made by the agency director or another
appropriate person. Procedures should be established to ensure each
panel's objectivity and currency in the field. Examples of other
procedures for selection of members of expert panels include
suggestions provided by the President of the National Academy of
Sciences, directors of institutes of the National Institutes of Health
and the National Science Foundation, and appropriate professional
societies.
Expert review panels could also be established outside NASA.
Subcommittee suggests, as two possibilities for consi'
National Academy of Sciences-National Research Counci
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The
National Institute for Occupational Safety and Health. Regardless of
which peer review system is selected, the names of the authors and
reviewers of a medical data sheet and the date of completion should be
stated on the data sheet.
NASA OCCUPATIONAL-HEALTH INFORMATION SYSTEM
In addition to providing specific guidance on the development of
medical surveillance data sheets, the Subcommittee examined the data
sheets in the context of an overall occupational-health system.
Chapter 4 identifies the objectives of such a system. Specific
recommendations are provided there to develop a population-based
health-information system that will provide, in a standardized format,
longitudinal health and safety records on all NASA employees. The
Subcommittee is aware that NASA has begun to explore the institution
of such a system and encourages activity in this direction. In view
of the substantial expenditure for health maintenan.:e and occupational
health surveillance, the Subcommittee believes that it would be well
worth the relatively small additional cost to ensure medical data
collection, storage, and linkage that would benefit both employer and
employee and improve clinical, epidemiologic, and toxicologic
evaluations.
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Exclusion Limit
FIGURE 1. Frequency distributions of results of a given test in
patients with and without a given disease. Note overlap between
two distribution curves.
- 24 -
QfP PAT*
FIGURE 2. Receiver-operator-characteristic (ROC) curve. True-positive
(TP) ratio is plotted against-false positive (FP) ratio.
True-positive ratio = (number positive tPscs in patients with
disease/number patients with disease tested). False positive ratio =
(number positive tests in patients without disease/number patients
without disease tested). If condition sought (for example,
consequence of workplace hazard) is severe, cutoff will be selected
near point E; if it is relatively trivial, cutoff will be selected
closer to point A. ROC curves can also be used to co©pare tests for
effectiveness in detecting a disease or exposure. The test that gives
an ROC curve closest to the upper left-hand corner of the graph is the
preferred one (it will have a better true-positive ratio for every
false-positive ratio). Reprinted with permission from McNeil et al.,
1975.
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TABLE 1. EFFECT OF INCREASING NUMBER OF TESTS ON
LIKELIHOOD OF OBTAINING ABNORMAL RESULTS IN
NORMAL PERSON
Percentage of times an abnormal
Number of indepenaent tests	 result is found
1 5
2 10
4 19
6 26
10 40
20 64
50 92
90 99
i
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